Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses
Viruses · 2023
DOI: 10.3390/v15020413 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2023. Verfasst von Tyler J Ogorek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA. Hauptthemen laut MEDLINE: Encephalomyelitis, Equine, Alphavirus. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Venezuelan, western, and eastern equine encephalitic alphaviruses (VEEV, WEEV, and EEEV, respectively) are arboviruses that are highly pathogenic to equines and cause significant harm to infected humans. Currently, human alphavirus infection and the resulting diseases caused by them are unmitigated due to the absence of approved vaccines or therapeutics for general use. These circumstances, combined with the unpredictability of outbreaks—as exemplified by a 2019 EEE surge in the United States that claimed 19 patient lives—emphasize the risks posed by these viruses, especially for aerosolized VEEV and EEEV which are potential biothreats. Herein, small molecule inhibitors of VEEV, WEEV, and EEEV are reviewed that have been identified or advanced in the last five years since a comprehensive review was last performed. We organize structures according to host- versus virus-targeted mechanisms, highlight cellular and animal data that are milestones in the development pipeline, and provide a perspective on key considerations for the progression of compounds at early and later stages of advancement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
- Division of Pharmaceutical Sciences, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.
ORCID-Profile: Tyler J Ogorek, Jennifer E Golden
Förderung
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Ogorek, T. J., & Golden, J. E. (2023). Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses. Viruses. https://doi.org/10.3390/v15020413
Vancouver
Ogorek TJ, Golden JE. Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses. Viruses. 2023. doi:10.3390/v15020413
BibTeX
@article{Ogorek2023,
author = {Ogorek, Tyler J and Golden, Jennifer E},
title = {Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15020413}
}
EUVIMED